Both in Biotechnology
Tenaya Therapeutics vs Champions Oncology
Over the past year TNYA returned −74.0% and CSBR returned −27.9%; their daily moves had a correlation of -0.00.
TNYA −74.0% CSBR −27.9%Growth of $1, one year, split-adjusted
| Metric | TNYA | CSBR |
|---|---|---|
| Price | $0.3725 | $4.90 |
| Market cap | $84.9M | $68.2M |
| Today | +3.19% | +1.87% |
| 1 month | −34.0% | −1.4% |
| 6 months | −50.6% | −17.9% |
| Year to date | −47.6% | −29.1% |
| 1 year | −74.1% | — |
| Revenue growth (YoY) | — | +8.8% |
| Gross margin | 100.0% | 50.5% |
| Net margin | −3909.3% | −2.8% |
| P/E (TTM) | — | — |
| Price / sales | 63.6× | 1.1× |
| Net cash | $78.1M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 78.3% | 35.6% |
| Short % of float | 13.1% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).